CCRP practice question 1 of 25
The study coordinator for a new Phase III vaccine study is preparing documents for IRB/IEC submission. According to the ICH GCP Guidelines, which of the following documents should be included in the submission?
Full set: 130 questionsDomain Recruiting, Screening, and Enrolling Study Subjects
ICH-GCP requires that any materials used to recruit or inform prospective subjects (e.g., advertisements, flyers, web postings) be reviewed and approved by the IRB/IEC before use. Section 3.1.2 states that the IRB/IEC “…should review… especially the written informed-consent form(s) and any subject-recruitment procedure (e.g., advertisements).” Recruitment materials are therefore an obligatory part of the submission package for a Phase III vaccine trial. The other listed documents are either not required for IRB/IEC review or are only filed with the sponsor and investigator.
A. Local laboratory normal ranges (ICH E6 8.2.11) are filed with investigator and sponsor; no IRB/IEC review required.
B. Blank CRFs may accompany the protocol (ICH E6 8.2.3) but are not specifically mandated for IRB/IEC submission and are seldom requested.
D. Investigator CVs (ICH E6 8.2.10) document qualifications for sponsor and site files; ICH does not require them to be sent to the IRB/IEC.
1. International Council for Harmonisation. ICH E6(R2) Good Clinical Practice Guideline. Section 3.1.2, p. 22; Section 4.4.3, p. 27; Section 8.2.7, p. 38.
2. FDA Guidance for IRBs, Clinical Investigators, and Sponsors: “Recruiting Study Subjects,” July 2018, pp. 2-3.
3. University of Michigan IRBMED Policy: “IRB Review of Advertisements and Recruitment Materials,” Rev. 2022, pp. 1-2 (illustrates standard application of ICH 3.1.2 requirements).
Keep practicing
Take the free CCRP practice test
Ten exam-style questions with answers and explanations, plus the exam facts and study guides.
More questions
Other CCRP practice questions
- Question 2In a completed multi-site Phase I drug study using remote EDC, who ensures the system com…
- Question 3Which of the following is an example of an additional protection required when conducting…
- Question 4A clinical investigator is planning to conduct a quality of life medical device study in …
- Question 5In accordance with the ICH GCP Guideline, prior to initiating a trial, which of the follo…
- Question 6According to the CFR and the ICH GCP Guideline, which of the following must be submitted …
- Question 7In accordance with ICH, which of the following is an acceptable protocol review frequency…
